MedTrace Logo

Improving End of Life Care in Head and Neck Cancer

NCT01632969 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2015-03-06

No results posted yet for this study

Summary

The purpose of this study is to improve the quality of care provided for head and neck cancer patients. By better understanding the end of life experiences of dying patients and their families, the investigators hope to better anticipate and improve upon the experiences of future patients and their families.

Conditions

  • The Families or Next of Kin of Patients Treated at MSKCC for Non-cutaneous Squamous Cell Carcinomas of the
  • Upper Aerodigestive Tract

Interventions

BEHAVIORAL

The The Family Assessment of Treatment at the End of life (FATE ) survey

Study candidates will be contacted by mail with an initial contact letter with information explaining the study, and then will receive a follow-up phone call to discuss their participation in the study no later than 1 month following the posting of the initial contact letter. If a family member or next-of-kin chooses to participate, verbal informed consent will be obtained over the phone and a one-time telephone interview will be conducted.

Sponsors & Collaborators

Principal Investigators

  • Snehal Patel, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01632969 on ClinicalTrials.gov